A new trading day began on Monday, with Pacific Biosciences of California Inc (NASDAQ: PACB) stock price down -3.88% from the previous day of trading, before settling in for the closing price of $1.29. PACB’s price has ranged from $0.85 to $2.72 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -23.55%. Meanwhile, its annual earnings per share averaged 6.94%. With a float of $264.16 million, this company’s outstanding shares have now reached $300.04 million.
Let’s determine the extent of company efficiency that accounts for 575 employees. In terms of profitability, gross margin is 16.17%, operating margin of -519.0%, and the pretax margin is -431.71%.
Pacific Biosciences of California Inc (PACB) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Pacific Biosciences of California Inc is 11.97%, while institutional ownership is 65.75%. The most recent insider transaction that took place on May 19 ’25, was worth 5,200. In this transaction an insider of this company sold 5,195 shares at a rate of $1.00, taking the stock ownership to the 269,259 shares. Before that another transaction happened on Mar 03 ’25, when Company’s insider sold 12,497 for $1.41, making the entire transaction worth $17,583. This insider now owns 2,225,357 shares in total.
Pacific Biosciences of California Inc (PACB) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 6.94% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.35% during the next five years compared to -23.55% drop over the previous five years of trading.
Pacific Biosciences of California Inc (NASDAQ: PACB) Trading Performance Indicators
Here are Pacific Biosciences of California Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.77, a number that is poised to hit -0.17 in the next quarter and is forecasted to reach -0.54 in one year’s time.
Technical Analysis of Pacific Biosciences of California Inc (PACB)
Looking closely at Pacific Biosciences of California Inc (NASDAQ: PACB), its last 5-days average volume was 11.29 million, which is a jump from its year-to-date volume of 10.25 million. As of the previous 9 days, the stock’s Stochastic %D was 52.87%.
During the past 100 days, Pacific Biosciences of California Inc’s (PACB) raw stochastic average was set at 32.23%, which indicates a significant decrease from 42.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.38% in the past 14 days, which was lower than the 97.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1254, while its 200-day Moving Average is $1.5679. However, in the short run, Pacific Biosciences of California Inc’s stock first resistance to watch stands at $1.3050. Second resistance stands at $1.3700. The third major resistance level sits at $1.4100. If the price goes on to break the first support level at $1.2000, it is likely to go to the next support level at $1.1600. Should the price break the second support level, the third support level stands at $1.0950.
Pacific Biosciences of California Inc (NASDAQ: PACB) Key Stats
With a market capitalization of 372.11 million, the company has a total of 300,085K Shares Outstanding. Currently, annual sales are 154,010 K while annual income is -309,850 K. The company’s previous quarter sales were 37,150 K while its latest quarter income was -426,080 K.
